Myxomas are benign mesenchymal tumors of uncertain etiology. Th ey can arise from odontogenic tissue, as well as from the sinonasal tract and from the facial and temporal bones, apparently from nonodontogenic mesenchyme. Although histologically benign, myxomas are locally invasive. Histopathology demonstrates a characteristically hypocellular lesion with loose stellate cells. We describe the case of a 48-year-old woman with a nonodontogenic maxillary sinus myxoma that invaded the sphenoid sinus and pterygopalatine fossa. We removed the mass via a combined endoscopic and gingivobuccal approach. Th e rarity of a nonodontogenic sinonasal myxoma extending into the sphenoid sinus and pterygopalatine fossa is the basis for our presentation of this case.
Introduction
Myxomas are benign mesenchymal tumors of uncertain etiology. Th e fi rst report of a myxoma was published in 1871 by Virchow, who described a mucinous tissue of the umbilical cord. 1 Th e origin of myxomas can be odontogenic or osteogenic. Most odontogenic tumors arise from periodontal ligaments, dental follicles, or dental papillae. Th ey are oft en associated with missing or impacted teeth. Most odontogenic masses have been seen in the jaws of young adults. 2 Although histologically benign, myxomas are locally invasive. Th ey usually grow slowly and expand with insidious infi ltration. Myxomas are rare, especially in the head and neck. When they have occurred in this region, they usually have been asymptomatic. In this article, we describe a new case of nonodontogenic myxoma of the head and neck.
Case report
A 48-year-old woman presented with a 2-year history of left -sided nasal obstruction, epistaxis, anosmia, and facial pain. She reported no trismus, and she exhibited no evidence of a tumor in the nasopharynx. Physical examination revealed the presence of a tumor in the left nasal cavity. Computed tomography (CT) of the paranasal sinuses demonstrated the mass in the left maxillary sinus (fi gure 1). Th e mass had widened the ostiomeatal complex, protruded into the nasal cavity, invaded the left posterior ethmoid cells and the left side of the sphenoid sinus, and extended into the pterygopalatine fossa. Erosion of the superior wall of the maxillary sinus and medial wall of the orbit was evident. A punch biopsy obtained from the nasal cavity demonstrated that the lesion was a low-grade myxoid mesenchymal tumor.
We chose to approach the tumor through a gingivobuccal incision with the patient under general anesthesia. Th e anterior wall and part of the medial wall of the left maxillary sinus were removed. Orbital invasion through the superior wall of the maxillary sinus was minimal, and the tumor did not penetrate into the orbit itself. Th e tumor was scraped beneath the orbital periosteum. Intraoperative frozen-section histopathology was performed to confi rm that the surgical margins were clear. the nasal cavity, anterior ethmoid cells, sphenoid sinus, and pterygopalatine fossa. Th e infi ltrative capacity of these lesions is perhaps enhanced by their gelatinous and friable nature. 8 Th ey expand locally, and despite their benign character, they grow aggressively and destroy adjacent tissues. 3 Myxomas of bone have been reported to develop primarily in facial bones. 3 Myxomas of the head and neck are extremely rare tumors. Andrews et al reported only 7 cases of myxoma of the head and neck that were removed surgically at their clinics over a 25-year period. 9 Perzin et al found only 6 myxomas among 256 nonepithelial tumors involving the nasal cavity, paranasal sinuses, and nasopharynx. 10 Surgery is the treatment of choice for maxillary sinus myxoma. 8, 11 However, there is debate as to which procedure is optimal. Recommendations range from enucleation or curettage to extensive surgery with wide margins. Th e latter option is based on the fact that myxomas have a strong tendency to quickly recur, especially those that arise from bone. 3 Also, there is concern that simple curettage is liable to leave minute fragments of tumor embedded in the tissue margin. In our patient, we Grossly, the tumor was characterized by a glistening, yellow, lobulated surface. Histologically, it was composed of oval nucleated bipolar cells with some stellate projections embedded in a myxoid stroma (fi gure 2, A). Immunohistochemical staining revealed that the tumor cells were positive for smooth-muscle actin (SMA) (fi gure 2, B) and negative for S-100 protein and CD34; however, a positive reaction for CD34 was seen in the vessel walls.
In view of the high rate of recurrence associated with this tumor, 3 the patient was scheduled to return for follow-up every 3 months. One year postoperatively, she exhibited no evidence of recurrence either endoscopically or radiologically.
Discussion
Histopathologically, myxomas characteristically appear as hypocellular lesions with loose stellate cells. Th ey feature long, branching cytoplasmic processes dispersed in an abundant, amorphous, faintly basophilic myxoid matrix. Th e matrix is rich in acid mucopolysaccharides, and it contains 80% hyaluronic acid and 20% chondroitin sulfate. 4 Myxomas can be diffi cult to diagnose because their histologic features can be confused with those of other conditions, such as rhabdomyosarcoma (embryonal or botryoid), rhabdomyoma, neurofi broma, fi bromyxoma, fi brous histiocytoma, chondromyxoid fi broma, myxoid chondrosarcoma, mucoid liposarcoma, and neurogenic sarcoma. Moshiri et al demonstrated on light microscopy the presence of spindle-shaped cells surrounded by amorphous material representing abundant ground substance. 5 Th eir immunohistochemical examinations revealed that the tumor cells were positive for vimentin, a panmesenchymal marker, and also for actin. Immunohistochemical staining in our case showed that the tumor cells were positive for SMA and negative for S-100 protein and CD34, although we found a positive reaction of CD34 in the vessel walls.
Myxomas may also develop in the sinonasal tract and in the facial and temporal bones, apparently from nonodontogenic mesenchyme. 6, 7 Our patient's tumor had completely fi lled the left maxillary sinus and extended to were able to remove the tumor with negative margins, as confi rmed by intraoperative frozen-section histopathology. However, we recommended close follow-up at 3-month intervals.
Other management modalities can be diffi cult; this entity is unresponsive to chemotherapy and poorly responsive to radiotherapy. 11 No metastatic potential has been reported. 
